Israel’s life science industry is recognized as fact-growing, vibrant force with a strong global reputation, yet Israeli companies have been producing medical devices and pharmaceuticals for more than a century. Teva pharmaceutical, the first Israeli pharma company, was established in 1901. By 1994, there were 88 life sciences companies-and from that point, the industry took off.

The advent of advanced technologies in the late 1990s changed the face of Israel’s life sciences industry. With proven capabilities in electronics, communications, computer science, and electro-optics, the country’s scientist and engineers joined forces to take medical devices to a new level and to introduce world-class innovations in digital imaging, medical lasers, electro-medical devices, telemedicine, surgical equipment, diagnostic kits, and rehabilitation equipment.

A World Marketer

Israeli life sciences companies export their products around the world, with main markets in the United States and the EU. Some companies establish subsidiaries in the United States or other locations for marketing and sales, others for strategic alliances for marketing, distribution, manufacturing and service.

Israel’s Life Sciences by the Numbers

Israeli companies are involved in a spectrum of solutions for a wide range of medical fields. Areas of primary focus include cardiovascular, operating room (OR) and emergency room (ER), neurology, oncology, obstetrics / gynecology (OB/GYN), orthopedics, ophthalmology, infectious diseases, wound management, and gastroenterology (GI).Israel is ranked second in the world for its medical device solutions for disposable and implantable, diagnostic and imaging. Medical device companies represent more than 54% of the country’s estimated 700 life sciences companies, with biotechnology the second largest sector.

Although half of the country’s life sciences companies are less than five years old, 40% generated revenues. In 2004, exports reached $1.1 billion from medical devices and $1.5 billion from pharmaceuticals and biotechnology – a total of $2.6 billion comprising 11.5% of Israel’s total industry exports.

Medical device exports reached $898 million in 2004. Total exports for life sciences industry in the first three quarters of 2005, an increase of 39% over the same period in 2004. The geographical distribution of life sciences exports is North America, 63%, Europe 27% and Asia 7%.

The life sciences industry employs 26,000 workers. Several well-established pharmaceutical companies focusing on generic drug production are among the country’s largest employers.

An Israeli National Export Organization

The IEICI is a non-profit organization founded in 1958 as a joint venture between Israeli government and private sector to promote Israels exports. The Israel export institute currently represents and serves virtually the entire industrial community in Israel. The institute is governed by a board of directors representing Israel’s leading export companies and economic organizations, primarily from the private sector.

Israel Export & International Cooperation Institute

The Israel Export & International Cooperation Institute is the primary organization facilitating trade opportunities, joint ventures, and strategic alliances between international businesses and Israeli companies.

They established to promote Israel’s industrial capabilities through business cooperation on all levels technological, industrial and commercial.

Their mission is to introduce to Israeli companies globally and to provide all the assistance and information on Israeli economy, development and market prospects required in order to establish strong, long term business contact with leading trade companies in Israel.
The key contact in India is
Mr. Ajay K.Lalan
(Business Associate Biomed 2007), “Vijaya”, Walji Ladha Road,
Mulund (w), Mumbai – 00 080.
Ph. :022-25600301, (m) 98202 9044,
email:export.israel.india@gmail.com

Page 1  2  3  4  5